Want to see IN:NEOGEN full AI Analyst Report?
NEOGEN Stock Chart & Stats
₹2063.35
₹1.30(0.06%)
At close: 4:00 PM EDT
₹2063.35
₹1.30(0.06%)
Day’s Range― - ―
52-Week Range₹978.00 - ₹2,482.70
Previous CloseN/A
Volume149.32K
Average Volume (3M)9.36K
Market Cap
₹61.37B
Enterprise Value₹43.23K
Total Cash (Recent Filing)₹49.50M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)175.8
Beta1.49
Next Earnings
Nov 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.04%
Share Statistics
EPS (TTM)13.25
Shares Outstanding26,381,674
10 Day Avg. Volume1,157
30 Day Avg. Volume9,357
Financial Highlights & Ratios
PEG Ratio-5.85
Price to Book (P/B)3.59
Price to Sales (P/S)3.40
P/FCF Ratio-3.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)22.54
Revenue Forecast (FY)₹12.44B
Bulls Say, Bears Say
Bulls Say
Multi-year Revenue GrowthSustained expansion over several years indicates growing product demand and market reach. Although the latest year brought profitability pressure, the enlarged revenue base can support operating leverage if margins and capacity utilization recover.
Specialty Chemical PositioningSpecialty intermediates typically require customer-specific specifications, qualification, and consistent quality. These requirements can support repeat B2B relationships and create barriers to switching compared with more commoditized chemical products.
End-market DiversificationExposure to multiple downstream industries reduces reliance on one customer segment and provides several avenues for growth. Lithium-related capacity adds participation in battery supply chains while the established bromine business supports diversification.
Bears Say
Margin CompressionThe sharp deterioration suggests weaker pricing, adverse product mix, or higher input costs, reducing earnings resilience. Sustained pressure would limit internal funding for expansion and make revenue growth less valuable to shareholders.
Higher LeverageThe rapid debt build materially increases financial risk while profitability and return on equity have weakened. Higher interest and refinancing requirements could constrain investment flexibility and amplify the impact of operating setbacks.
Negative Cash GenerationDeeply negative operating and free cash flow indicates that current operations and investment needs are absorbing substantial liquidity. Combined with higher debt, this increases dependence on external financing and raises execution risk during capacity expansion.
Neogen Chemicals Ltd. News
NEOGEN FAQ
What was Neogen Chemicals Ltd.’s price range in the past 12 months?
Neogen Chemicals Ltd. lowest stock price was ₹978.00 and its highest was ₹2482.70 in the past 12 months.
What is Neogen Chemicals Ltd.’s market cap?
Neogen Chemicals Ltd.’s market cap is ₹61.37B.
When is Neogen Chemicals Ltd.’s upcoming earnings report date?
Neogen Chemicals Ltd.’s upcoming earnings report date is Nov 06, 2026 which is in 78 days.
How were Neogen Chemicals Ltd.’s earnings last quarter?
Neogen Chemicals Ltd. released its earnings results on Jul 24, 2026. The company reported ₹6.2 earnings per share for the quarter, beating the consensus estimate of ₹5.14 by ₹1.06.
Is Neogen Chemicals Ltd. overvalued?
According to Wall Street analysts Neogen Chemicals Ltd.’s price is currently Overvalued.
Does Neogen Chemicals Ltd. pay dividends?
Neogen Chemicals Ltd. pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.04%. See more information on Neogen Chemicals Ltd. dividends here
What is Neogen Chemicals Ltd.’s EPS estimate?
Neogen Chemicals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Neogen Chemicals Ltd. have?
Neogen Chemicals Ltd. has 26,381,674 shares outstanding.
What happened to Neogen Chemicals Ltd.’s price movement after its last earnings report?
Neogen Chemicals Ltd. reported an EPS of ₹6.2 in its last earnings report, beating expectations of ₹5.14. Following the earnings report the stock price went down -1.128%.
Which hedge fund is a major shareholder of Neogen Chemicals Ltd.?
Currently, no hedge funds are holding shares in IN:NEOGEN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Neogen Chemicals Ltd.
Neogen Chemicals Limited, founded in Thane, India, in 1989, is engaged in the manufacturing and supply of an extensive array of specialized chemical products. The company's comprehensive portfolio encompasses numerous organo-bromine compounds, including alkyl bromides, dibromoalkanes, bromo chloro alkanes, various bromine derivatives (of organoacids, esters, aromatics, and cyclics), and specialty bromo-fluoro derivatives. Additionally, Neogen offers specialty chloro compounds, unsaturated and bromo-hydroxy derivatives, inorganic bromine compounds, lithium salts, Grignard reagents, and advanced intermediates. Beyond its product range, the firm also provides custom synthesis and contract manufacturing services. Neogen's offerings cater to diverse industrial sectors such as pharmaceuticals, agrochemicals, engineering, flavors and fragrances, electronic chemicals, refrigeration, construction, specialty polymers, and heating, ventilation, and air conditioning (HVAC). The company maintains an international presence, exporting its chemicals to 28 nations globally.
Technical Analysis
Alkyl Amines Chemicals Limited
―
Balaji Amines Limited
―
Laxmi Organic Industries Ltd.
―
Tatva Chintan Pharma Chem Limited
―
Vishnu Chemicals Limited
―